
IT-Revisor (m/w/d) für unsere Abteilung Interne Revision
Hausbank München eG Bank für Haus- und Grundbesitz

Hausbank München eG Bank für Haus- und Grundbesitz
SEH Engineering GmbH

Hotel Bayerischer Hof
WERNER companies GmbH

My Humancapital GmbH

Hotel Bayerischer Hof
Pfennigparade Ernst-Barlach-Schulen GmbH
AllcuraMed Personal GmbH München

Orizon GmbH, Unit Aviation
Oberlandesgericht München
All Inclusive Fitness

Kreissparkasse München Starnberg Ebersberg

MÜNCHENSTIFT GmbH Gemeinnützige Gesellschaft der Landeshauptstadt
BRUNATA-METRONA GmbH & Co. KG
Eva Rex
JOBAG Personal GmbH
Verlag C.H.Beck GmbH & Co. KG
Institut für Zeitgeschichte
SIS-Sparkassen-Immobilien-Service GmbH
Elektro Kreutzpointner GmbH
KW Consult GmbH

GVG Immobilien Service GmbH
TTI Personaldienstleistung GmbH - München

Gemeinnützige Gesellschaft für soziale Dienste - DAA - mbH
TTI Personaldienstleistung GmbH - München
Geiger Gruppe

M&H Personalservice GmbH
Staatliches Bauamt Freising
Geiger Gruppe
Akkodis Germany Tech Experts GmbH
JOBAG Personal GmbH

Hotel Bayerischer Hof

Orizon GmbH, Unit Aviation
Geiger Gruppe
EY Consulting GmbH
Lehmann Personalmanagement GmbH
LEASOTEC GmbH
Verbraucherzentrale Bayern e.V.

Kinderkrippe Die Klosterspatze

Kinderkrippe Die Klosterspatzen e.V.

GVG Immobilien Service GmbH

ProSiebenSat.1 Media SE
ADAC SE

NTT DATA Deutschland SE
FALKEN Group
be4work GmbH NL München

NTT DATA Deutschland SE

ahead professionals GmbH
MVI PERSONAL POWER GmbH

hubside - Die Recruitingwerkstatt


Dissecting genomic and post-transcriptional processes and their dynamics in pancreatitis and pancreatic cancer.
Our research focuses on genomic and post-transcriptional processes that facilitate tumor evolution, tumor heterogeneity, metastasis, and drug resistance in cancer. We aim to understand the dynamics of genome editing on the DNA and RNA level, cellular signaling, and their impact on the microenvironment in the context of inflammatory diseases and cancer. We employ cutting-edge computational biology methods to identify genomic aberrations, mutations, and post-transcriptional processes. In addition, we aim to verify those findings functionally and mechanistically with various molecular biology assays using a broad range of in vitro and in vivo platforms, including genetically engineered 2D/3D cell-, organoid- and mouse models, and human specimens.
Our overall goal is to gain a better mechanistic understanding that can be leveraged to identify novel treatment approaches to improve the clinical outcome in patients with inflammatory diseases and cancer. Our lab is currently growing to establish versatile cancer genomics, proteomics, and cell biology platforms to make an impact on the development of novel therapies.
Klinik und Poliklinik für Innere Medizin II
TUM Klinikum Rechts der Isar Ismaninger Straße 22 81675 München
If the candidates’ suitability for the position in question is equal, severely disabled applicants shall be given preference. Interview-related costs can, unfortunately, not be reimbursed.